Their lead product, the VentFree™ respiratory muscle stimulator, applies proprietary electrical stimulation to the expiratory muscles in sync with exhalation during mechanical ventilation. This breakthrough therapy aims to reduce abdominal muscle atrophy and the time patients spend on mechanical ventilation, potentially leading to improved quality of life, reduced morbidity and mortality, and significant cost savings for healthcare providers. Founded in 2013 and headquartered in Crestwood, Kentucky, Liberate Medical develops neuromuscular electrical stimulation technology for patients with respiratory failure.